in

A clinical research and manufacturing facility proposed for Sydney

A state significant development application has been lodged for the establishment of a RNA Pilot Research and Manufacturing Facility, designed by HDR and sited at Macquarie University’s Wallumattagal campus in North Ryde.

The facility, located approximately 13km from the Sydney CBD, the facility on the corner of Gymnasium and Culloden Roads would be used to manufacture vaccines and treatments for clinical trials, as well as undertake research studies.

Envisaged as a “pavilion in the trees,” the design responds to its natural context by adopting a colour palette that matches the surrounding native trees – a dark base with a light coloured roof – and uses vertical elements to reference the surrounding forest. The application also proposes construction of an internal road, upgrades to the existing car park, and landscaping to provide natural shade and social lawns.

The proposal has been categorized as a significant state development, with the design report stating the facility would “boost innovation and technology in NSW, centralize RNA knowledge and expertise,” and aid the state in becoming a global front runner of RNA research.

The site of the proposed facility is located next to an existing car park and is connected by public transport, including a number of bus routes and nearby train station.

The project would target a 5-star Green Star Buildings rating.

The Department of Planning and Environment received a state significant development (SSD) application from the Health Administration Corporation and the proposal is now in the exhibition phase.


Source: Architecture - architectureau

Two Dozen Artists Gather a Diverse Flock of Avians at Brassworks Gallery for ‘Birds Rising’

Best in Class at the 2023 Australian Good Design Awards